NRAS and melanoma: By analyzing the different responses to immunotherapy in patients with NRAS mutations between cutaneous and noncutaneous melanoma, we analyzed the association of NRAS mutation with immunotherapy outcome in Asian melanoma population and tried to identify potential treatment strategies for these patients.